Revolution Medicines · 1 day ago
Senior Scientist I, Analytical Development
San Francisco Bay Area
Full-time
Onsite
Senior Level
$149K/yr - $186K/yr
5+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Senior Scientist I in Analytical Development will support the manufacturing and control of drug substances and products during clinical development, providing analytical support and collaborating with cross-functional teams.
Health CareLife ScienceMedical
Responsibilities
Provide support and oversight to analytical development activities, such as method development, method validation and testing, at contract partner sites to ensure outsourced activities are executed successfully and meet the objectives
Provide analytical support for API process R&D and manufacturing, formulation development and drug product manufacturing, and participate in cross-functional project team meetings
Critically review data packages associated with method validations, release testing, and other characterization testing for drug substances and drug products
Collaborate with cross functional teams in the establishment of control strategy and setting specifications for drug substances and drug products
Prepare, review, and/or approve study protocols, study reports, and CMC regulatory submission document
Communicate technical findings to colleagues and collaborators within formal and informal settings, including cross-functional project team meetings
Collaborate with cross functional teams including but not limited to Medicinal Chemistry, DMPK, Toxicology, QA, Pharmaceutical Development, Process R&D, Project Management and Regulatory to timely achieve project goals
Present work and results in team and group meetings
Qualification
Required
Ph.D. with a min of 5 years industry experience or MS degree with a min of 8 years of relevant industrial experience in analytical development
Technical knowledge of analytical technologies including HPLC/UPLC, XRPD, LCMS, DSC, DVS and Dissolution
Experience managing projects at CROs/CDMOs
Experience with analytical method development, validation and method transfer
Work experience and knowledge of regulatory submission (IND, IMPD, and / or NDA)
Knowledge and understanding of current ICH guidelines, GMP guidelines, and related industry practices
Strong problem-solving skills with sound technically driven decision-making ability
Excellent scientific and business communication skills (verbal, written and technical), strong interpersonal/collaboration skills and planning skills
Ability to think critically and creatively and be able to work independently to determine appropriate resources for resolution of problems
Ability to multi-task and thrive in a fast-paced innovative environment
Preferred
PhD or MS in analytical chemistry, organic chemistry, or related discipline
CMC experience with small Molecules is strongly desired, and experience in solid oral dosage is a plus
Familiarity with document management systems (such as Veeva or similar)
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
2026-01-09
2026-01-09
Company data provided by crunchbase